Cover Image

Unique pharmacology of a novel allosteric agonist/sensitizer insulin receptor monoclonal antibody

Objective: Insulin resistance is a key feature of Type 2 Diabetes (T2D), and improving insulin sensitivity is important for disease management. Allosteric modulation of the insulin receptor (IR) with monoclonal antibodies (mAbs) can enhance insulin sensitivity and restore glycemic control in animal...

Full description

Saved in:
Bibliographic Details
Main Authors: Simon A. Hinke (Author), Anne M. Cieniewicz (Author), Thomas Kirchner (Author), Katharine D'Aquino (Author), Rupesh Nanjunda (Author), Jason Aligo (Author), Robert Perkinson (Author), Philip Cooper (Author), Ken Boayke (Author), Mark L. Chiu (Author), Steve Jarantow (Author), Eilyn R. Lacy (Author), Yin Liang (Author), Dana L. Johnson (Author), Jean M. Whaley (Author), Russell B. Lingham (Author), Anthony J. Kihm (Author)
Format: Book
Published: Elsevier, 2018-04-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items